MOMO'S BREAKOUT BOARD

[goodibag]

OMHE_Developed_Marijuana_based_Medicine_Starting_FDA_Registration_Process


12/05/2017 MMJ Medicine Development & FDA Approval Plan News - Read Here

Omni Health has started the process of reformulating its most successful proprietary formularies to include cannabidiol (CBD) and commence its FDA Medical Devices registration for topical pain analgesic.

OMHE’s_ Cannabidiol_Products_To_Be_Exported_To_Europe._Capturing_Pain_Treatment_Market

Link To 11/14/2017 OMHE CEO Letter

We will continue to provide updates over the coming weeks that will include a collaboration/joint venture with one of the largest European cannabis companies pertaining to the import and distribution of breakthrough cannabidiol-centered consumer products that we are presently developing for them. The first steps in the commercialization process will involve the establishment of a strong presence in the European market, the benefits of which will be elaborated upon in future communications.